Dr Reddy's Laboratories sued over cancer drug patent

Sanofi-Aventis' fully owned subsidiary - Genzyme Corporation, has filed a suit against Dr Reddy's Laboratories, alleging that it has infringed on patents of its cancer drug Mozobil (Plerixafor injection) on three counts.


Patent wars

In its petition, Genzyme alleged that Dr Reddy's had intimated through a letter that it had submitted an Abbreviated New Drug Application (ANDA) with the US FDA for approval to engage in the commercial manufacture, importation, use and sale of 20 mg/ml Plerixafor injection as a generic version of Mobozil.

Leave a Reply Sign in

Notify me of follow-up comments via e-mail address

Post Comment

Survey Box

National Health Policy

Is National Health Policy 2017 helpful for patients?

Send this article by email